Treatment of hypertension and prevention of dementia

Alzheimer's and Dementia

Volumn 1, Issue 1, 2005, Pages 30-37

  Hanon, Olivier ^a   Forette, Françoise ^a  

^a Paris Descartes University   (France)

Author keywords

Antihypertensive treatment; Cognitive decline; Dementia; Hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HYDROCHLOROTHIAZIDE; INDAPAMIDE; NITRENDIPINE; PERINDOPRIL; PLACEBO; RAMIPRIL;

AGING; ALZHEIMER DISEASE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DRUG MECHANISM; EPIDEMIOLOGICAL DATA; HUMAN; HYPERTENSION; INCIDENCE; MULTIINFARCT DEMENTIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PUBLIC HEALTH SERVICE; REVIEW; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 32144463790     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2005.06.022     Document Type: Review

References (62)

1. J.M. Starr L.J. Whalley S. Inch P.A. Shering Blood pressure and cognitive function in healthy old people J Am Geriatr Soc 41 1993 753-756
2. M.L. Seux L. Thijs F. Forette J.A. Staessen W.H. Birkenhager C.J. Bulpitt et. al. Correlates of cognitive status of old patients with isolated systolic hypertension: The Syst-Eur Vascular Dementia Project J Hypertens 16 1998 963-969
3. M.E. Farmer L.R. White R.D. Abbott S.J. Kittner E. Kaplan M.M. Wolz et. al. Blood pressure and cognitive performance; The Framingham study Am J Epidemiol 126 1987 1103-1114
4. P.A. Scherr L.E. Hebert L.A. Smith D.A. Evans Relation of blood pressure to cognitive functions in the elderly Am J Epidemiol 134 1991 1303-1315
5. M.F. Elias P.A. Wolf R.B. d'Agostino J. Cobb L.R. White Untreated blood pressure level is inversely related to cognitive functioning: The Framingham Study Am J Epidemiol 138 1993 353-364
6. L. Kilander H. Nyman M. Boberg L. Hansson H. Lithell Hypertension is related to cognitive impairment: A 20-year follow-up of 999 men Hypertension 31 1998 780-786
7. C. Tzourio C. Dufouil P. Ducimetiere A. Alperovitch Cognitive decline in individuals with high blood pressure Neurology 53 1999 1948-1952
8. D. Knopman L.L. Boland T. Mosley G. Howard D. Liao M. Szklo et. al. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Cardiovascular risk factors and cognitive decline in middle-aged adults Neurology 56 2001 42-48
9. L.J. Launer G.W. Ross H. Petrovitch K. Masaki D. Foley L.R. White et. al. Midlife blood pressure and dementia: The Honolulu-Asia aging study Neurobiol Aging 21 2000 49-55
10. M. Kivipelto E.L. Helkala M.P. Laakso T. Hanninen M. Hallikainen K. Alhainen et. al. Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal, population based study BMJ 322 2001 1447-1451
11. C. Qiu B. Winblad M. Viitanen L. Fratiglioni Pulse pressure and risk of Alzheimer disease in persons aged 75 years and older: A community-based, longitudinal study Stroke 34 2003 594-599
12. R.A. Whitmer S. Sidney J. Selby S.C. Johnston K. Yaffe Midlife cardiovascular risk factors and risk of dementia in late life Neurology 64 2005 277-281
13. I. Skoog B. Lernfelt S. Landahl B. Palmertz L.A. Andreasson L. Nilsson et. al. A 15-year longitudinal study of blood pressure and dementia Lancet 347 1996 1141-1145
14. O. Hanon F. Latour M.L. Seux H. Lenoir F. Forette A.S. Rigaud Evolution of blood pressure in patients with Alzheimer's disease: A one year survey of a French cohort (REAL.FR) J Nutr Health Aging 9 2005 106-111
15. J. Verghese R.B. Lipton C.B. Hall G. Kuslansky M. Katz Low blood pressure and the risk of dementia in very old individuals Neurology 61 2003 1667-1672
16. Z. Guo M. Viitanen L. Fratiglioni B. Winblad Low blood pressure and dementia in elderly people: The Kungsholmen project BMJ 312 1996 805-808
17. W.J. Burke P.G. Coronado C.A. Schmitt K.M. Gillespie H.D. Chung Blood pressure regulation in Alzheimer's disease J Auton Nerv Syst 48 1994 65-71
18. K.M. Bellew J.G. Pigeon P.E. Stang W. Fleischman R.M. Gardner W.W. Baker Hypertension and the rate of cognitive decline in patients with dementia of the Alzheimer type Alzheimer Dis Assoc Disord 18 2004 208-213
19. S.R. Heckbert W.T. Longstreth B.M. Psaty et. al. The association of antihypertensive agents with MRI white matter findings and with modified Mini-Mental State Examination in older adults J Am Geriatr Soc 45 1997 1423-1433
20. C.J. Maxwell D.B. Hogan E.M. Ebly Calcium-channel blockers and cognitive function in elderly people: Results from the Canadian Study of Health and Aging CMAJ 161 1999 501-506
21. J.S. Meyer B.W. Judd T. Tawaklna R.L. Rogers K.F. Mortel Improved cognition after control of risk factors for multi-infarct dementia JAMA 256 1986 2203-2209
22. Z. Guo L. Fratiglioni L. Zhu J. Fastbom B. Winblad M. Viitanen Occurrence and progression of dementia in a community population aged 75 years and older: Relationship of antihypertensive medication use Arch Neurol 56 1999 991-996
23. J.M. Starr L.J. Whalley I.J. Deary The effects of antihypertensive treatment on cognitive function: Results from the HOPE study J Am Geriatr Soc 44 1996 411-415
24. M.D. Murray K.A. Lane S. Gao R.M. Evans F.W. Unverzagt K.S. Hall et. al. Preservation of cognitive function with antihypertensive medications: A longitudinal analysis of a community-based sample of African Americans Arch Intern Med 162 2002 2090-2096
25. M.J. Prince A.S. Bird R.A. Blizard A.H. Mann Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults BMJ 312 1996 801-805
26. SHEP Cooperative Research Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP) JAMA 265 1991 3255-3264
27. M. Di Bari M. Pahor L.V. Franse R.I. Shorr J.Y. Wan L. Ferrucci et. al. Dementia and disability outcomes in large hypertension trials lessons: learned from the systolic hypertension in the elderly program (SHEP) trial Am J Epidemiol 153 2001 72-78
28. F. Forette M.L. Seux J.A. Staessen L. Thijs W.H. Birkenhager M.R. Babarskiene et. al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial Lancet 352 1998 1347-1351
29. F. Forette M.L. Seux J.A. Staessen L. Thijs M.R. Babarskiene S. Babeanu et. al. Systolic Hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: New evidence from the Systolic Hypertension in Europe (Syst-Eur) study Arch Intern Med 162 2002 2046-2052
30. C. Tzourio C. Anderson N. Chapman M. Woodward B. Neal S. MacMahon et. al. PROGRESS Collaborative Group Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease Arch Intern Med 163 2003 1069-1075
31. J. Bosch S. Yusuf J. Pogue P. Sleight E. Lonn B. Rangoonwala et. al. HOPE Investigators Heart outcomes prevention evaluation. Use of ramipril in preventing stroke: Double blind randomised trial BMJ 324 2002 699-702
32. H. Lithell L. Hansson I. Skoog D. Elmfeldt A. Hofman B. Olofsson et. al. SCOPE Study Group The Study on Cognition and Prognosis in the Elderly (SCOPE): Principal results of a randomized double-blind intervention trial J Hypertens 21 2003 875-886
33. Z.S. Khachaturian Calcium hypothesis of Alzheimer's disease and brain aging Ann N Y Acad Sci 747 1994 1-11
34. M. Kawahara Y. Kuroda Intracellular calcium changes in neuronal cells induced by Alzheimer's beta-amyloid protein are blocked by estradiol and cholesterol Cell Mol Neurobiol 21 2001 1-13
35. C. O'Neill R.F. Cowburn W.L. Bonkale T.G. Ohm J. Fastbom M. Carmody et. al. Dysfunctional intracellular calcium homoeostasis: A central cause of neurodegeneration in Alzheimer's disease Biochem Soc Symp 67 2001 177-194
36. I. Veinbergs A. Everson Y. Sagara E. Masliah Neurotoxic effects of apolipoprotein E4 are mediated via dysregulation of calcium homeostasis J Neurosci Res 67 2002 379-387
37. M.P. Mattson H. Zhu J. Yu M.S. Kindy Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: Involvement of perturbed calcium homeostasis J Neurosci 20 2000 1358-1364
38. M.P. Mattson B. Cheng D. Davis K. Bryant I. Lieberburg R.E. Rydel β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity J Neurosci 12 1992 376-389
39. M. Sabbatini F. Mignini D. Venarucci J.A. Vega F. Amenta Effect of nicardipine treatment on the expression of neurofilament 200 KDa immunoreactivity in the brain of spontaneously hypertensive rats Clin Exp Hypertens 23 2001 127-141
40. A. Arregui E.K. Perry M. Rossor B.E. Tomlinson Angiotensin converting enzyme in Alzheimer's disease increased activity in caudate nucleus and cortical areas J Neurochem 38 1982 1490-1492
41. D.A. Snowdon L.H. Greiner J.A. Mortimer K.P. Riley P.A. Greiner W.R. Markesbery Brain infarction and the clinical expression of Alzheimer disease The Nun Study. JAMA 277 1997 813-817
42. J. Victoroff W.J. Mack S.A. Lyness H.C. Chui Multicenter clinicopathological correlation in dementia Am J Psychiatry 152 1995 1476-1484
43. K. Jellinger W. Danielczyk P. Fischer E. Gabriel Clinicopathological analysis of dementia disorders in the elderly J Neurol Sci 5 1990 239-258
44. M.M. Breteler J.C. van Swieten M.L. Bots D.E. Grobbee J.J. Claus J.H. van den Hout et. al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study the: Rotterdam study Neurology 44 1994 1246-1252
45. F. Pasquier D. Leys Why are stroke patients prone to develop dementia? J Neurol 244 1997 135-142
46. L.S. Perlmutter E. Barron D. Saperia H.C. Chui Association between vascular basement membrane components and the lesions of Alzheimer's disease J Neurosci Res 30 1991 673-681
47. J.A. Hardy D.M. Mann P. Wester B. Winblad An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease Neurobiol Aging 7 1986 489-502
48. R.N. Kalaria P. Hedera beta-Amyloid vasoactivity in Alzheimer's disease Lancet 347 1996 1492-1493
49. F. Wilkie C. Eisdorfer Intelligence and blood pressure in the aged Science 172 1971 959-962
50. J. Launer K. Masaki H. Petrovitch D. Foley R.J. Havlik The association between midlife blood pressure levels and late-life cognitive function The Honolulu-Asia Aging Study. JAMA 274 1995 1846-1851
51. T. Yoshitake Y. Kiyohara I. Kato T. Ohmura H. Iwamoto K. Nakayama et. al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study Neurology 45 1995 1161-1168
52. J.M. Starr I.J. Deary S. Inch S. Cross W.J. MacLennan Blood pressure and cognitive decline in healthy old people J Hum Hypertens 11 1997 777-781
53. G.E. Swan D. Carmelli A. Larue Systolic blood pressure tracking over 25 to 30 years and cognitive performance in older adults Stroke 29 1998 2334-2340
54. F. Reinprecht S. Elmstahl L. Janzon L. Andre-Petersson Hypertension and changes of cognitive function in 81-year-old men: A 13-year follow-up of the population study 'Men born in 1914', Sweden J Hypertens 21 2003 57-66
55. O. Piguet D.A. Grayson H. Creasey H.P. Bennett W.S. Brooks L.M. Waite et. al. Vascular risk factors, cognition and dementia incidence over 6 years in the Sydney Older Persons Study Neuroepidemiology 22 2003 165-171
56. K. Okumiya K. Matsubayashi T. Wada Y. Osaki Y. Doi T. Ozawa J-curve relation between blood pressure and decline in cognitive function in older people living in community, Japan J Am Geriatr Soc 45 1997 1032-1033
57. R.J. Glynn L.A. Beckett L.E. Hebert M.C. Morris P.A. Scherr D.A. Evans Current and remote blood pressure and cognitive decline JAMA 281 1999 438-445
58. A.D. Bohannon G.G. Fillenbaum C.F. Pieper J.T. Hanlon D.G. Blazer Relationship of race/ethnicity and blood pressure to change in cognitive function J Am Geriatr Soc 50 2002 424-429
59. Z. Guo L. Fratiglioni B. Winblad M. Viitanen Blood pressure and performance on the Mini-Mental State Examination in the very old Am J Epidemiol 145 1997 1106-1113
60. L. Zhu M. Viitanen Z. Guo B. Winblad L. Fratiglioni Blood pressure reduction, cardiovascular diseases and cognitive decline in the Mini-Mental State Examination in a community population of normal very old people: A three-year follow-up J Clin Epidemiol 51 1998 385-391
61. J. Verghese R.B. Lipton C.B. Hall G. Kuslansky M. Katz Low blood pressure and the risk of dementia in very old individuals Neurology 61 2003 1667-1672
62. M.C. Morris P.A. Scherr L.E. Hebert R.J. Glynn D.A. Bennett D.A. Evans Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study Arch Neurol 58 2001 1640-1646